Early-Stage vs. Late-Stage 409A: What Changes as You Scale
A 409A valuation evolves dramatically as a company scales. At pre-seed, valuations use asset-based methods with CVM allocation and high marketability discounts (30–50%). By Series A, OPM Backsolve becomes the standard as priced rounds provide market anchors. At growth stage (Series C+), PWERM models discrete exit scenarios with probability weights. At pre-IPO, SEC scrutiny intensifies, DLOM compresses to 5–15%, and common stock converges to 80–95%+ of preferred value.
The companies that handle this best treat the 409A as a living document that reflects their actual stage, risk profile, and proximity to liquidity — not a compliance checkbox.
A 409A valuation at a pre-seed company looks almost nothing like a 409A valuation at a pre-IPO company. The legal requirement is the same—establish the fair market value of common stock for stock option pricing under IRC Section 409A—but the methodologies, inputs, complexity, costs, scrutiny, and strategic implications change dramatically as a company scales.
Founders who understand these differences make better decisions about when to refresh their valuations, what to expect from their valuation provider, and how to avoid the mistakes that create problems during fundraising, audits, and exit transactions.
This guide walks through the full lifecycle of a 409A valuation—from the earliest stages through pre-IPO—and explains exactly what changes at each stage and why.
The 409A Process: A Quick Refresher
Regardless of stage, every 409A valuation follows the same three-step framework:
- Determine enterprise value. Estimate what the entire company is worth using one or more accepted valuation approaches (market, income, or asset).
- Allocate value to common stock. Divide total enterprise value among all equity classes—preferred stock, common stock, options, warrants—based on their economic rights. This accounts for liquidation preferences, conversion rights, participation features, and other terms that make preferred stock worth more than common stock.
- Apply a discount for lack of marketability (DLOM). Reduce the per-share value of common stock to reflect the fact that privately-held shares cannot be freely traded on a public market.
What changes across stages is how each step is performed—the methods, the inputs, the level of scrutiny, and the resulting common-to-preferred ratio.
Stage-by-Stage: How 409A Valuations Evolve
The Starting Point
At the earliest stages, the company has little or no revenue, limited financial history, and often hasn’t completed a priced equity round. Valuations are driven more by qualitative factors than quantitative metrics.
- Enterprise value approach: Asset-based method or market approach using comparable early-stage transactions. If the company has raised on SAFEs or convertible notes, there may not be a priced round to backsolve from.
- Equity allocation: Current Value Method (CVM) — allocates value based on what each class would receive if the company were liquidated today. Simple to apply but doesn’t capture upside optionality.
- DLOM: High — typically 30–50%. Highly illiquid with no secondary market activity.
- Common-to-preferred ratio: Low. Common stock often valued at 20–50% of the most recent valuation cap or SAFE price.
- Auditor involvement: Usually none.
- Update frequency: Every 12 months, or upon a material event.
- Cost: $2,000–$5,000.
The First Priced Round Changes Everything
A priced Series A round fundamentally changes the 409A landscape. For the first time, an arm’s-length transaction with an outside investor establishes a market-tested price for preferred stock—providing the most reliable anchor for the valuation.
- Enterprise value approach: OPM Backsolve becomes the dominant method. The appraiser calibrates the Option Pricing Model so that the value allocated to Series A preferred equals its issue price, then calculates implied common stock value.
- Equity allocation: Option Pricing Model (OPM) — treats each equity class as a call option on total equity value, with breakpoints determined by liquidation preferences and conversion thresholds.
- Key inputs: Expected volatility (60–90% for early-stage), expected time to liquidity (3–7 years), and risk-free rate.
- DLOM: Still significant — 25–40% — but often slightly lower as the financing provides some validation.
- Common-to-preferred ratio: Typically 25–45% of the preferred price per share.
- Auditor involvement: Often begins here. Institutional investors increasingly require audited financials by Series A.
- Cost: $3,000–$8,000.
Rising Complexity, Rising Stakes
By Series B, the company typically has meaningful revenue, a multi-layered capital structure with two or more classes of preferred stock, and auditors who are actively reviewing the 409A.
- Enterprise value approach: OPM Backsolve remains common, but the appraiser may also incorporate a market approach (guideline public company multiples) or preliminary income approach (DCF) as a reasonableness check.
- Equity allocation: OPM with increasingly complex waterfall modeling. Multiple series of preferred stock—each with different liquidation preferences, participation rights, and conversion terms—require careful breakpoint analysis.
- DLOM: Moderate — 20–35%. As exit probability increases, the discount narrows.
- Common-to-preferred ratio: Converges upward — 35–60% of the most recent preferred price.
- Auditor involvement: Standard. The 409A is a key input to ASC 718 stock-based compensation expense.
- Update frequency: Every 12 months minimum. Many companies begin semi-annual refreshes.
- Cost: $5,000–$15,000.
Exit Scenarios Come Into Focus
At the growth stage, exit scenarios become more concrete. The company may be evaluating strategic acquisitions, preparing for an IPO, or conducting secondary transactions.
- Enterprise value approach: Income approach (DCF) gains prominence with reliable financial projections. Market multiples become more meaningful with stronger comparable company sets.
- Equity allocation: Hybrid OPM/PWERM or full PWERM. Models specific exit scenarios (IPO at $X, M&A at $Y, continued operations) with probability weights.
- DLOM: Declining — 15–25%. Secondary market activity, if any, further reduces the discount.
- Common-to-preferred ratio: Approaching convergence — 50–80% of the most recent preferred price.
- Secondary transactions: Tender offers or other secondary liquidity programs provide direct market evidence and must be incorporated.
- Auditor involvement: Intensive. Auditors often participate in kick-off calls and review draft reports.
- Update frequency: Semi-annual minimum. Quarterly refreshes common for companies exploring exit.
- Cost: $10,000–$25,000+.
Maximum Complexity, Maximum Scrutiny
The pre-IPO phase represents the most complex and scrutinized period for 409A valuations. The SEC will review the company’s equity compensation history—typically 12 to 18 months before the IPO filing (and sometimes up to 2–3 years)—specifically looking for “cheap stock” issues where options were granted at strike prices that appear too low relative to the eventual IPO price.
- Enterprise value approach: Full income and market approaches with significant weight on observable data, including investment banker valuations, private placements, and secondary transaction prices.
- Equity allocation: PWERM with increasing weight on the IPO scenario (often 70–90%). Transition from pure OPM to hybrid/PWERM is expected.
- DLOM: Compressing rapidly — 5–15%. Quantitative put-option models estimate DLOM based on expected time to IPO. The SEC scrutinizes these closely.
- Common-to-preferred ratio: Near convergence — 80–95%+ of the implied per-share IPO price.
- SEC review: The Division of Corporation Finance reviews historical 409A valuations in S-1 filings. SAB 120 provides guidance on “spring-loaded” awards. Any significant disconnect requires explanation.
- Update frequency: Quarterly, often more frequently around S-1 filing, pricing meetings, or SEC comment responses.
- Cost: $15,000–$30,000+ per valuation, often with multiple updates per quarter.
The Full Comparison: Early-Stage to Pre-IPO
| Dimension | Pre-Seed / Seed | Series A | Series B | Series C+ | Pre-IPO |
|---|---|---|---|---|---|
| EV Method | Asset / Market | OPM Backsolve | Backsolve + Market/DCF | DCF + Market | Full Income + Market |
| Allocation | CVM | OPM | OPM (complex) | Hybrid / PWERM | PWERM |
| DLOM | 30–50% | 25–40% | 20–35% | 15–25% | 5–15% |
| Common / Preferred | 20–50% | 25–45% | 35–60% | 50–80% | 80–95%+ |
| Auditor Role | None | Begins | Standard | Intensive | Intensive + SEC |
| Update Cadence | Annual | Annual | Annual / Semi | Semi / Quarterly | Quarterly+ |
| Typical Cost | $2K–$5K | $3K–$8K | $5K–$15K | $10K–$25K+ | $15K–$30K+ |
Understanding the Allocation Methods
One of the most important changes as a company scales is the equity allocation method—the technique used to divide total enterprise value among preferred stock, common stock, and options.
| Method | How It Works | Best Suited For | Limitations |
|---|---|---|---|
| CVM | Allocates current enterprise value based on liquidation waterfall as if sold today | Pre-seed / Seed; very early-stage with limited data | Doesn’t capture upside optionality; undervalues common in growing companies |
| OPM | Treats each equity class as a call option on total equity value with breakpoints at liquidation preferences | Series A through growth stage; complex cap tables | Assumes a single distribution of outcomes; doesn’t model specific exit scenarios |
| PWERM | Models discrete exit scenarios (IPO, M&A, dissolution) with probability weights and allocates value under each | Late-stage and pre-IPO with identifiable exit paths | Requires estimating probabilities for specific outcomes; more subjective |
| Hybrid | Combines OPM allocation within one or more PWERM scenarios | Growth stage; mix of near-term visibility and long-term uncertainty | Most complex to implement; requires robust documentation |
The transition from CVM → OPM → PWERM/Hybrid isn’t just a methodological preference—it reflects the company’s evolving risk profile. Early-stage companies face enormous outcome uncertainty, making the probabilistic OPM appropriate. As exit scenarios become concrete, the scenario-based PWERM provides a more accurate allocation.
How the Discount for Lack of Marketability (DLOM) Evolves
The DLOM is one of the most impactful variables in a 409A valuation—and one of the most scrutinized. It represents the reduction in value applied to common stock because it cannot be freely traded on a public exchange.
| Stage | Typical DLOM | Rationale |
|---|---|---|
| Pre-Seed / Seed | 30–50% | Highly illiquid; no secondary market; significant uncertainty about future outcomes and timing of any liquidity event |
| Series A | 25–40% | Financing round provides some validation; still long time horizon to exit with substantial execution risk |
| Series B | 20–35% | Increasing exit probability; meaningful revenue provides anchor; auditors begin testing DLOM assumptions |
| Series C+ | 15–25% | Concrete exit visibility; potential secondary market activity; declining time-to-liquidity |
| Pre-IPO | 5–15% | Imminent public offering; quantitative put-option models used; SEC scrutinizes closely |
As the probability of a liquidity event increases and the expected time to that event decreases, the DLOM should decline. Auditors and the SEC will question any valuation where the DLOM does not reflect the company’s evolving liquidity profile.
What Founders Get Wrong at Each Stage
Early-Stage Mistakes
Granting options without a valuation — even at pre-seed — leaves you without a defensible basis for strike prices.
Saying “common is worth 10% of preferred” hasn’t been acceptable practice for over a decade. The IRS expects a formal analysis.
Thin reports won’t withstand scrutiny from the IRS, acquirers’ counsel, or auditors during due diligence.
Growth-Stage Mistakes
The prior valuation expires immediately upon a material event — not at the 12-month anniversary.
By Series B, your auditor should be reviewing the 409A and its assumptions. Surprises during audit season are expensive.
If you’re actively in M&A discussions or have filed confidential IPO paperwork, a PWERM or hybrid approach is more appropriate and defensible.
Late-Stage and Pre-IPO Mistakes
As the company approaches IPO, the SEC will question DLOMs that don’t decline in step with increasing IPO probability.
“Cheap stock” triggers SEC scrutiny and may require the company to record additional compensation expense.
Using OPM throughout and switching to PWERM only at the S-1 filing raises questions about consistency and timing of the methodological change.
Strategic Considerations: The 409A as a Management Tool
Beyond compliance, the 409A valuation has real strategic implications at every stage:
- Talent acquisition. A lower common stock value means a lower strike price, making options more attractive to prospective employees. But the value must be defensible—artificially depressed valuations create legal and tax risk.
- Option pool management. Understanding how common stock value trends over time helps founders plan option pool refreshes and anticipate the strike prices new hires will receive.
- Secondary transactions. The 409A often serves as a reference point for pricing secondary sales. Companies with accurate, current valuations have an easier time structuring these programs.
- M&A readiness. Acquirers review 409A history during due diligence. Clean, consistent valuations with defensible methodologies accelerate deal timelines and reduce renegotiation risk.
- Board governance. The board should formally approve option grants at 409A-supported strike prices. Maintaining a clear paper trail of board reliance on qualified valuations is essential for safe harbor protection.
The Bottom Line
Your 409A valuation should evolve with your company. A seed-stage valuation using the Current Value Method and a 40% DLOM is appropriate for a pre-revenue startup. That same approach would be indefensible for a Series C company with $50M in ARR and active IPO planning.
The companies that handle this best treat the 409A not as a compliance checkbox, but as a living document that reflects their company’s actual stage, risk profile, and proximity to liquidity. And they work with valuation providers who understand the full lifecycle—from the first option grant through the IPO or exit.
409A Valuations for Every Stage
Alpha Analytics provides 409A valuations for private companies from pre-seed through pre-IPO. Our credentialed appraisers deliver audit-ready reports using stage-appropriate methodologies—CVM, OPM, OPM Backsolve, PWERM, and Hybrid approaches—with the documentation and defensibility that auditors, investors, and the SEC expect.
We also provide ASC 718 fair value measurements, gift and estate tax valuations, and QSBS eligibility assessments.
Get Started →Frequently Asked Questions
How does a 409A valuation change from early-stage to late-stage?
At early stages, 409A valuations rely on asset-based methods or CVM allocation with high marketability discounts (30–50%) and low common-to-preferred ratios. As the company scales, methodology evolves to OPM Backsolve and eventually PWERM, discounts decline to 5–15% pre-IPO, common stock converges toward preferred, and auditor and SEC scrutiny intensifies significantly.
What is the difference between CVM, OPM, and PWERM?
CVM allocates value based on a hypothetical liquidation today — simple but doesn’t capture upside, used at pre-seed/seed. OPM treats each equity class as a call option on total equity value, appropriate from Series A through growth. PWERM models specific discrete exit scenarios with probability weights, used late-stage when exit paths become concrete.
How much does a 409A valuation cost at each stage?
Costs scale with complexity: pre-seed/seed runs $2,000–$5,000, Series A is $3,000–$8,000, Series B is $5,000–$15,000, growth stage (Series C+) is $10,000–$25,000+, and pre-IPO can cost $15,000–$30,000+ per valuation with multiple updates per quarter.
What is DLOM and how does it change over time?
DLOM (Discount for Lack of Marketability) reflects the reduced value of shares that can’t be freely traded. It starts at 30–50% for pre-seed companies and declines through each stage — reaching 5–15% pre-IPO — as the probability and proximity of a liquidity event increases.
What is “cheap stock” and why does the SEC care?
Cheap stock refers to options granted at strike prices that appear too low relative to the eventual IPO price. The SEC reviews 12–18 months (sometimes 2–3 years) of equity compensation history before an IPO. Significant disconnects require explanation and may result in additional stock-based compensation expense.
When should a company transition from OPM to PWERM?
When concrete exit scenarios become identifiable — typically at Series C+ when the company is actively exploring an IPO, evaluating strategic acquisitions, or has sufficient visibility into specific exit paths with estimable probabilities and timing.
How often should a 409A be updated?
At minimum every 12 months, but any material event (like a funding round) invalidates the current valuation immediately. Growth-stage companies typically refresh semi-annually, and pre-IPO companies update quarterly or more frequently around S-1 filings or SEC comment responses.
Important: The information in this article is for general educational purposes only and does not constitute tax, legal, or accounting advice. 409A compliance involves complex regulatory requirements that depend on specific facts and circumstances, including entity structure, capital structure, compensation design, and jurisdictional tax rules. Always consult with qualified tax attorneys, certified public accountants, or other licensed professionals before making decisions related to equity compensation or stock option pricing.